Free Trial

Amgen (AMGN) SEC Filings & 10K Form

Amgen logo
$263.38 +2.19 (+0.84%)
(As of 12/20/2024 05:40 PM ET)

Recent Amgen SEC Filings

DateFilerForm TypeView
12/06/2024
5:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:48 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:37 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:38 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:41 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:45 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:46 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:20 PM
Amgen (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/13/2024
4:44 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:41 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:00 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:23 PM
Amgen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/04/2024
6:26 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:27 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:28 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:31 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:32 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:33 PM
Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:22 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
6:23 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:24 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:25 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:17 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
5:59 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:00 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:03 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:04 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:05 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:06 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:08 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:56 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:57 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:58 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW
05/07/2024
7:31 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:32 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:33 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:34 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:35 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:37 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:39 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:25 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:48 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:17 PM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
6:18 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:19 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:20 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:22 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:23 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:24 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:25 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:59 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:00 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:01 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
7:44 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:51 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:53 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:54 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:55 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:04 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:05 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:07 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:09 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:10 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:11 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:12 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:59 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:00 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:34 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:25 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:26 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:29 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:31 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:32 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

03/08/2024
4:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:23 PM
Amgen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2024
6:50 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
10:35 AM
Amgen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMGN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners